Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

398 ARTÍCULOS , VIENDO DEL 76 AL 90

Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease

Wang T, Liu XH, Guan J, Ge S, Wu MB, Lin JP, Yang LR.

Eur J Med Chem. 2019 May 1;169:200-223. doi: 10.1016/j.ejmech.2019.02.076. Epub 2019 Mar 5.

Traditional Ayurvedic and herbal remedies for Alzheimer's disease: from bench to bedside

Sharma R, Kuca K, Nepovimova E, Kabra A, Rao MM, Prajapati PK.

Expert Rev Neurother. 2019 May;19(5):359-374. doi: 10.1080/14737175.2019.1596803. Epub 2019 Apr 10.

ApoE4: an emerging therapeutic target for Alzheimer's disease

Safieh M, Korczyn AD, Michaelson DM.

BMC Med. 2019 Mar 20;17(1):64. doi: 10.1186/s12916-019-1299-4.

Bioavailability and Pharmaco-therapeutic Potential of Luteolin in Overcoming Alzheimer's Disease

Ali F, Siddique YH.

CNS Neurol Disord Drug Targets. 2019;18(5):352-365. doi: 10.2174/1871527318666190319141835.

Targeting Inflammatory Pathways in Alzheimer's Disease: A Focus on Natural Products and Phytomedicines

Sharman MJ, Verdile G, Kirubakaran S, Parenti C, Singh A, Watt G, Karl T, Chang D, Li CG, Münch G.

CNS Drugs. 2019 May;33(5):457-480. doi: 10.1007/s40263-019-00619-1.

Safety and efficacy of active and passive immunotherapy in mild-to-moderate Alzheimer's disease: A systematic review and network meta-analysis

Foroutan N, Hopkins RB, Tarride JE, Florez ID, Levine M.

Clin Invest Med. 2019 Mar 23;42(1):E53-E65. doi: 10.25011/cim.v42i1.32393.

Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease

Pinheiro L, Faustino C.

Curr Alzheimer Res. 2019;16(5):418-452. doi: 10.2174/1567205016666190321163438.

The Role of Nutrition for the Aging Population: Implications for Cognition and Alzheimer's Disease

Power R, Prado-Cabrero A, Mulcahy R, Howard A, Nolan JM.

Annu Rev Food Sci Technol. 2019 Mar 25;10:619-639. doi: 10.1146/annurev-food-030216-030125.

[Caring for people suffering from Alzheimer's disease]

Chazot-Balcon M, Bouchard JP.

Rev Infirm. 2019 Jan;68(247):32-34. doi: 10.1016/j.revinf.2018.11.008.

Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer's disease

Zaplatic E, Bule M, Shah SZA, Uddin MS, Niaz K.

Life Sci. 2019 May 1;224:109-119. doi: 10.1016/j.lfs.2019.03.055. Epub 2019 Mar 23.

Current and Future Treatments in Alzheimer's Disease

Atri A.

Semin Neurol. 2019 Apr;39(2):227-240. doi: 10.1055/s-0039-1678581. Epub 2019 Mar 29.

Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis

Thancharoen O, Limwattananon C, Waleekhachonloet O, Rattanachotphanit T, Limwattananon P, Limpawattana P.

Drugs Aging. 2019 May;36(5):435-452. doi: 10.1007/s40266-019-00648-x.

Race reporting and disparities in clinical trials on Alzheimer's disease: A systematic review

Canevelli M, Bruno G, Grande G, Quarata F, Raganato R, Remiddi F, Valletta M, Zaccaria V, Vanacore N, Cesari M.

Neurosci Biobehav Rev. 2019 Jun;101:122-128. doi: 10.1016/j.neubiorev.2019.03.020. Epub 2019 Apr 1.

Pharmacokinetic Characterizations of Ginsenoside Ocotillol, RT5 and F11, the Promising Agents for Alzheimer's Disease from American Ginseng, in Rats and Beagle Dogs

Li Y, Hu H, Li Z, Li R, Xu F, Zhao C, An Y, Liu Y, Wang Z, Zhang B, Geng C.

Pharmacology. 2019;104(1-2):7-20. doi: 10.1159/000499595. Epub 2019 Apr 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias